GSMA Pushes for Global mHealth Solutions for Mobile Diabetes Monitoring

The GSMA is behind a new international campaign designed to raise awareness for how mHealth may provide answers for physicians and others looking to treat, prevent, and raise awareness about diabetes.

A disease that now affects close to 400 million people worldwide, diabetes has increasingly become a condition that can be effectively monitored and treated by doctors remotely, thereby similarly increasing the quality and frequency of care among these patients by medical professionals.

But the industry has a long way to go before its full potential has been reached, says the GSMA. As a result, the mDiabetes Campaign is designed to help medical professionals “better understand the commercial models for mDiabetes solutions that have launched or are in development, and to identify and address key market barriers, with the ultimate goal of stimulating the creating and delivery of clinically meaningful mDiabetes solutions.”

Given the sobering fact that the GSMA represents hundreds of mobile operators and related companies in well over 200 nations today, the reach of this initiative could have lasting impacts across the mHealth landscape.

“This is truly a global challenge, and one in all economies, not just the developing world,” says Jeanine Vos, executive director of GSMA mHealth. “There are a large amount of opportunities… I think every economy around the world recognizes the need to address this now,” added Michael Curran, director of the GSMA mDiabetes initiative. “It’s a growing epidemic … and measurement is quite easy to establish.”

With 552 million people projected to live with diabetes by 2030, the time couldn’t be more critical to get on board mHealth for the treatment of diabetes, says the organization.

To learn more about the effort, click here.

This post was written by:

- who has written 2290 posts on mHealthWatch.

Contact the author